One week left to register applications for the competition of clinical research projects in oncology
Applications submission is open for proposals of randomized clinical trials in oncology and related areas. Application due date is July 01, 2019. Online pre-registration is required by June 20, 2019...
RUSSIAN ONCOLOGISTS PROPOSED A NEW WAY TO PREVENT CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
Results of the clinical trial are presented today at the largest oncology ASCO meeting in Chicago, USA...
RESULTS OF THE SUPPORTED RESEARCH ON LUNG CANCER DIAGNOSTIC PLATFORM DEVELOPMENT
В Санкт-Петербурге завершилось второе исследование, поддержанное исследовательским грантом RUSSCO и РакФонда для молодых ученых и начинающих исследователей в области онкологии... Результаты проведенного исследования будут в ближайшее время опубликованы в специализированных изданиях...
RAKFOND HAS JOINED “NUZHNA POMOSCH” PLATFORM
RakFond has successfully completed an expert assessment and became a participant on the platform "Nuzhna pomosch". From now on, donations for RakFond can be made through the platform. In addition, anyone can organize a fundraising event for RakFond at https://sluchaem.ru...
FINAL RESULTS OF THE RESEARCH SUPPORTED BY RAKFOND ARE PUBLISHED
American Society of Clinical Oncology (ASCO) released the materials of the upcoming Annual Meeting in Chicago on May 31 - June 4, 2019. The oral presentation of the final results of the randomized phase II trial, supported by RakFond, will be given by its author Dr. Alexey Rumyantsev during the Symptoms and Survivorship session...
RAKFOND ANNOUNCES A NEW COMPETITION TO SUPPORT CLINICAL RESEARCH
Foundation for Cancer Research Support (RakFond) opens applications submission for the competition of clinical research projects in oncology...
STUDY SUPPORTED BY RAKFOND WILL BE PRESENTED AT ASCO ANNUAL MEETING
Final results of the randomized phase II trial supported by Rakfond will be presented by its author Dr. Alexey Rumyantsev at the Annual Meeting of the American Society of Clinical Oncology (ASCO)...
FIRST RESEARCH SUPPORTED BY RAKFOND HAS BEEN COMPLETED
The clinical trial to evaluate the efficacy of the novel drug combination for chemotherapy-induced nausea & vomiting (CINV) prophylaxis has been successfully completed...
WINNER THE ONCOMMUNOLOGY COMPETITION WILL STUDY EFFICACY MECHANISMS OF A NEW CELL IMMUNOTHERAPY
The winner of the research project competition funded jointly by RakFond and SciStoreLab, LLC is Dr. Emil Bulatov,...
RESULTS OF THE RESEARCH PROJECTS COMPETITION RFP 2018-02
The research project competition funded jointly by the NPO “Foundation for Cancer Research Support” (RakFond) and SciStoreLab, LLC has been completed...
